(Reuters) – Johnson & Johnson expects to share details on the company’s late-stage COVID-19 vaccine trial early next week, Chief Executive Officer Alex Gorsky said at a post-earnings conference call on Tuesday.
(Reporting by Manas Mishra in Bengaluru; Editing by Shailesh Kuber)
Nadal’s clay game is rounding into form just in time for the French Open. ‘Things are happening.’
Paying college athletes appears closer than ever. How could it work and what stands in the way?
Wood scores 11:03 in OT as Avalanche finish off 3-goal comeback to beat Stars 4-3 to open 2nd round
Gilgeous-Alexander has 29 points to help Thunder roll past Mavericks in Game 1 of West semifinals
Trocheck’s power-play goal lifts Rangers to 4-3 win over Hurricanes in 2OT for 2-0 series lead
High school students, frustrated by lack of climate education, press for change
Biden heads to Wisconsin to laud a new Microsoft facility, meet voters — and troll Trump
Oddly-dressed perp grabs two cellphones during Midtown 1 train robbery: cops
Most FTX customers to get all their money back less than 2 years after catastrophic crypto collapse
Thailand’s prime minister wants to outlaw cannabis, 2 years after it was decriminalized
Thailand’s prime minister wants to outlaw cannabis, 2 years after it was decriminalized
European Medicines Agency pulls authorization for AstraZeneca’s COVID shot, at company’s request
Can you afford to take care of your children and parents? Biden revives effort to lower costs
Louisiana lawmakers reject adding exceptions of rape and incest to abortion ban
